In addition, we assessed the other genes in TCGA database (Supplementary figure 3), and the expression of CDH11X, TEX13A, LOR and GLRX2 showed good correlation with the survival outcomes of ESCC patients, but all the genes were barely reported as immune‐related functions. The gene discussed is GLRX2; the disease is esophageal squamous cell carcinoma.